Published in Vaccine Weekly, August 6th, 2003
Jun Zhao and colleagues at the National Cancer Center in Bethesda, Maryland, the Duke University Medical Center in Durham, North Carolina, and Advanced BioScience Laboratories, Inc., in Kensington, Maryland "investigated the ability of a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen to induce protective immunity in rhesus macaques against pathogenic simian immunodeficiency...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly